DR. GIL Y MELMED M.D.
Prescription History 1336102524
Internal Medicine - Gastroenterology in Los Angeles, CA
Quality Rating: 88.46 out of 100 score
NPI Status: Active since April 10, 2006
Contact Information
8635 W 3RD ST
SUITE 960-W
LOS ANGELES, CA
ZIP 90048
Phone: (310) 201-6514
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions DR. GIL Y MELMED M.D. has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Mesalamine
- Specialty
- Gastroenterology
- Times Prescribed
- 11
- Number of 30-Day Refills Prescribed
- 13
- What is this prescription?
- An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
- What is this prescription used for?
- This medication is used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. Mesalamine belongs to a class of drugs known as aminosalicylates. It works by decreasing swelling in the colon.
- Generic Name
- Pantoprazole Sodium
- Specialty
- Gastroenterology
- Times Prescribed
- 17
- Number of 30-Day Refills Prescribed
- 17
- What is this prescription?
- 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
- What is this prescription used for?
- Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).
- Generic Name
- Ustekinumab
- Specialty
- Gastroenterology
- Times Prescribed
- 32
- Number of 30-Day Refills Prescribed
- 37.2
- What is this prescription?
- A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
- What is this prescription used for?
- Ustekinumab is used to treat plaque psoriasis, a certain type of arthritis (psoriatic arthritis), or certain bowel conditions (Crohn's disease, ulcerative colitis). It works by blocking certain natural proteins in your body (interleukin-12 and interleukin-23) that cause inflammation (swelling) in these conditions. Ustekinumab does not cure these diseases, but helps to lessen symptoms of the disease. It can help to decrease the amount of plaques in plaque psoriasis, decrease the number of swollen/painful joints in psoriatic arthritis, and decrease symptoms such as abdominal pain/cramping and diarrhea in Crohn's disease and ulcerative colitis.
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.